Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
100424-1 8(9)-Cholestenol MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE 8(9)-Cholestenol [Mass/volume] in Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/L &nbsp; &nbsp; < or = 5.0 mg/L &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100424-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 8(9)-Cholestenol SerPl-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/L &nbsp; &nbsp; &nbsp; 0
100425-8 DiHydro T-Mas MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE DiHydro T-Mas [Mass/volume] in Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/L &nbsp; &nbsp; < or = 0.3 mg/L &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100425-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 SerPl-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 4,4-dimethyl-5�±-cholest-8-en-3�²-ol; 4,4-dimethyl-cholest-8(9)-en-3�²-ol; Chemistry; DiHydro testis meiosis activating sterol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/L &nbsp; &nbsp; &nbsp; 0
100426-6 Squalene MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Squalene [Mass/volume] in Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/L &nbsp; &nbsp; < or = 1.0 mg/L &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100426-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Squalene SerPl-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/L &nbsp; &nbsp; &nbsp; 0
100427-4 Stigmasterol MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Stigmasterol [Mass/volume] in Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/L &nbsp; &nbsp; < or = 0.5 mg/L &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100427-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Stigmasterol SerPl-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/L &nbsp; &nbsp; &nbsp; 0
100428-2 Carnitine Free & Total & Acylcarnitine Panel - Urine Pt - &nbsp; &nbsp; ACTIVE Carnitine free and total and acylcarnitine panel - Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 100428-2 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Carnitine + acylcarnitine Pnl Ur &nbsp; &nbsp; &nbsp; N &nbsp; Acyl carnitine; Acylcarni; Acylcarnitine Pnl; Carnitine + acylcarnitine Pnl; Carnitine.total; Chemistry; FR; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Tot; Totl; UA; UR; Urn 2.78 2.73 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.78: CLASS: Corrected the class to PANEL.CHEM; 0
100429-0 Lipopolysaccharide-responsive beige-like anchor protein deficiency panel - Bld Pt - &nbsp; &nbsp; ACTIVE LRBA deficiency panel - Blood &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CELLMARK &nbsp; 100429-0 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 LRBA deficiency panel Bld &nbsp; &nbsp; &nbsp; N &nbsp; Blood; CELL MARKERS; LRBA deficiency panel; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; PR; Prot; Random; WB; Whole blood 2.73 2.73 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
10043-8 S wave amplitude.lead V4 Elpot Heart Pt Qn EKG &nbsp; ACTIVE S wave amplitude in lead V4 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10043-8 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 S wave Amp L-V4 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-V4; S wave Amp L-V4; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
100430-8 Cells.LRBA+/Cells.CD3+CD14-CD45+ NFr Bld Pt Qn Flow cytometry &nbsp; ACTIVE Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100430-8 &nbsp; Flow cytometry &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cells.LRBA+/T Cells NFr Bld FC &nbsp; &nbsp; &nbsp; N &nbsp; B220; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; LCA; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; Monocytes; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T Cells; T200; T3; WB; Whole blood 2.79 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
100431-6 Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity Arb Bld Pt Qn Flow cytometry &nbsp; ACTIVE Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) &nbsp; ADD DefinitionDescription &nbsp; &nbsp; Arb U &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100431-6 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T-cells LRBA MFI Bld FC &nbsp; &nbsp; &nbsp; N &nbsp; Arbitrary; Average; Avg; B220; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; LCA; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; T-cells LRBA MFI; WB; Whole blood 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U] &nbsp; &nbsp; &nbsp; 0
100432-4 Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ NFr Bld Pt Qn Flow cytometry &nbsp; ACTIVE Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100432-4 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Cells.LRBA+/B Cells NFr Bld FC &nbsp; &nbsp; &nbsp; N &nbsp; B Cells; B220; B4; B-4; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HD-37; LCA; Leu12; Leu-12; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood 2.79 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
100433-2 Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity Arb Bld Pt Qn Flow cytometry &nbsp; ACTIVE Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) &nbsp; ADD DefinitionDescription &nbsp; &nbsp; Arb U &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100433-2 &nbsp; Flow cytometry &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 B-cells LRBA MFI Bld FC &nbsp; &nbsp; &nbsp; N &nbsp; Arbitrary; Average; Avg; B220; B4; B-4; B-cells LRBA MFI; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HD-37; LCA; Leu12; Leu-12; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U] &nbsp; &nbsp; &nbsp; 0
100434-0 Orthopoxvirus.non-variola DNA PrThr XXX Pt Ord Probe.amp.tar &nbsp; ACTIVE Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 100434-0 &nbsp; Probe.amp.tar &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Nonvar Orthpx DNA Spec Ql NAA+probe &nbsp; &nbsp; &nbsp; N &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nonvar Orthpx; Nonvar Orthpx DNA; Nucleic acid sequence based analysis; Ordinal; Orthopox virus; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100435-7 Glial fibrillary acidic protein MCnc Ser Pt Qn IA &nbsp; ACTIVE Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 100435-7 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 GFAP Ser IA-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; EIA; ELFA; ELISA; Enzyme immunoassay; GFAP; IAA; Level; Mass concentration; MEIA; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Stroke; SUDS; TBI (Traumatic Brain Injury); Traumatic Brain Injuries 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; 0
100436-5 Ubiquitin carboxyl-terminal hydrolase-L1 MCnc Ser Pt Qn IA &nbsp; ACTIVE Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 100436-5 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 UCH-L1 Ser IA-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; TBI (Traumatic Brain Injury); UCH-L1 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; 0
100437-3 Norsufentanil MCnc Urine Pt Qn Confirm &nbsp; ACTIVE Norsufentanil [Mass/volume] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 100437-3 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Norsufentanil Ur Cfm-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; 0
100438-1 Progress note Find Outpatient Pt Doc Adolescent medicine &nbsp; ACTIVE Adolescent medicine Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100438-1 &nbsp; Adolescent medicine &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Adolescent med OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100439-9 Progress note Find Outpatient Pt Doc Allergy+Immunology &nbsp; ACTIVE Allergy and Immunology Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100439-9 &nbsp; Allergy+Immunology &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Allergy+Immunology OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
10044-6 S wave amplitude.lead V5 Elpot Heart Pt Qn EKG &nbsp; ACTIVE S wave amplitude in lead V5 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10044-6 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 S wave Amp L-V5 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-V5; S wave Amp L-V5; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
100440-7 Progress note Find Outpatient Pt Doc Allergy &nbsp; ACTIVE Allergy Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100440-7 &nbsp; Allergy &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Allergy OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100441-5 Progress note Find Outpatient Pt Doc Attending &nbsp; ACTIVE Attending Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100441-5 &nbsp; Attending &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Attend OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100442-3 Progress note Find Outpatient Pt Doc Audiology &nbsp; ACTIVE Audiology Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100442-3 &nbsp; Audiology &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Audiology OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100443-1 Progress note Find Outpatient Pt Doc Bariatric surgery &nbsp; ACTIVE Bariatric surgery Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100443-1 &nbsp; Bariatric surgery &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Bariatric surg OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Metabolic and bariatric surgery; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100444-9 Progress note Find Outpatient Pt Doc Blood banking and transfusion medicine &nbsp; ACTIVE Blood banking and transfusion medicine Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100444-9 &nbsp; Blood banking and transfusion medicine &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Bld Bnk+Trans Med OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; Bld Bnk+Trans Med; Blood conservation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Tx; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100445-6 Progress note Find Outpatient Pt Doc Bone marrow transplant &nbsp; ACTIVE Bone Marrow Transplant Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100445-6 &nbsp; Bone marrow transplant &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 BM Transplant OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; BM Transplant; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100446-4 Progress note Find Outpatient Pt Doc Breastfeeding &nbsp; ACTIVE Breastfeeding Outpatient Progress note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 100446-4 &nbsp; Breastfeeding &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Breastfeeding OP Prog note &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note 2.73 2.73 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104,672 results found